Overexpressed Mirna-137 Inhibits Human Glioma Cells Growth by Targeting Rac1

Guan Sun,Ying Cao,Lei Shi,Lihua Sun,Yingyi Wang,Chen,Zhengqiang Wan,Linshan Fu,Yongping You

DOI: https://doi.org/10.1089/cbr.2012.1380

2013-01-01

Cancer Biotherapy and Radiopharmaceuticals

Abstract:Previous studies have shown that miR-137 functions as a tumor suppressor in various cancers, but its role in the initiation and development of gliomas is still unknown. Currently, we found that miR-137 exhibited the most significant increase in normal brain tissues compared with glioma specimens, and the miR-137 expression was greatly decreased with the ascending of tumor pathological grades. Furthermore, overexpression of miR-137 in vitro by chemically synthesized miR-137 mimics suppressed the proliferation, inhibited cell cycle arrest in the G1/G0 phase, and induced cell apoptosis. The tumor-suppressive effects of miR-137 were indeed induced by Rac1, which was verified as a direct target of miR-137. These findings indicate that miR-137 inhibits the growth of gliomas cells by directly targeting Rac1, suggesting that miR-137 could be a new important therapeutic strategy for glioma treatment and warrants further investigation.